Thursday, April 03, 2008

Aubrey Blumsohn on "corporate bullying"

Bloggers discussing the intimidation of a patient, Bob Fiddaman, by GlaxoSmithKline

1 comment:

Anonymous said...

It happens in several of the us pharama companies as a Chemist for 17 years I am surprised when a lot of this stuff hits the market especially since they knew it was no good on the bench or through analytical. We just have the big boys turning a blind eye in order to get paid.